NMDA-Antagonisten

European patent · EP0418863 · Deleted

Register entry

Publication number
EP0418863
Application number
EP90118033
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 19, 1990
Published
Mar 27, 1991
Granted
Jan 4, 1995
Deleted
Sep 30, 2002
Reason
Annual fee unpaid
IPC classes
C07F 9/6509 (2006.01)
A61K 31/675 (2006.01)
C07F 9/653 (2006.01)
C07F 9/38 (2006.01)
Priority
US A 409478 19.09.1989
US A 508333 11.04.1990
US A 553431 20.07.1990
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 15, 2003

    Deleted, fee unpaid

    Published in +pat+ No 9 in 2003

  2. Feb 15, 1995

    Granted

    Published in PIDTJ No 3 in 1995

Parties

Holder

Merrell Dow Pharmaceuticals Inc.

2110 E. Galbraith Road, Cincinnati/OH, US

Agent

E. Blum & Co. Patentanwälte

Am Vorderberg 11, 8044 Zürich

Inventor

Whitten, Jeffrey P.

Cincinnati, Ohio 45241, US

Baron, Bruce M.

Cincinnati, Ohio 45215, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.